NCT05422534View on ClinicalTrials.gov

CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 20, 2027

Study Completion Date

October 1, 2027

Conditions
End Stage Renal Disease
Interventions
DIETARY_SUPPLEMENT

CoQ10

Participants will receive 1800 mg/day for 12 weeks

DRUG

Placebo

Participants will receive placebo or CoQ10/day for 12 weeks

BEHAVIORAL

HB-HIIT

Participants will be performed on non dialysis days. It will be video supervised exercise sessions with self directed exercises using pre-recorded bodyweight and strength exercise videos.

BEHAVIORAL

Observational

Participant regular activities

Trial Locations (2)

37232

RECRUITING

Vanderbilt University Medical Center-GCRC, Nashville

95817

NOT_YET_RECRUITING

University of California Davis Health, Sacramento

All Listed Sponsors
collaborator

University of California, Davis

OTHER

lead

Vanderbilt University Medical Center

OTHER